Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-26-007571
Filing Date
2026-08-03
Accepted
2026-08-03 16:51:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5692
  Complete submission text file 0001950047-26-007571.txt   7284
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37722 | Film No.: 261233918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SPYRE THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 105 WALTHAM MA 02453
Business Address
Burrows Scott L (Reporting) CIK: 0001853327 (see all company filings)

Type: 144